N4 Pharma plc (N4P) ORD GBP0.004
- Add to watchlist
- Create an alert
- This stock can be held in a
0.61p
0.61p
1.30p
£2.37 million
0.61p
0.50p
0.41p
n/a
0.06p (10.91%) Previous:
0.06p
404,047
n/a
150,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (£m) | n/a | n/a |
Profit before tax (£m) | (1.43) | (1.19) |
Adjusted EPS (p): | (0.52) | (0.55) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
N4 Pharma reports positive progress with SRI collaboration
20 August 2024 10:10
-
N4 Pharma shares tank after £0.6m fundraise
7 June 2024 11:06
-
N4 Pharma shares jump on latest Nuvec developments
15 February 2024 13:17
-
Interim Results
24 September 2024 07:00
-
SRI Research Update
17 September 2024 08:04
-
Change of Auditor
23 August 2024 08:30
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.